Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in H1 2023

European Healthtech startup funding raised during H1 2023.

In H1 2023, 302 European Healthtech companies closed 309 funding rounds and raised €2.7B in equity funding (excluding debt and grants), down 34.1% versus H1 2022. Debt rounds added €228M. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€2.7B
-34.1% vs H1 2022 · excl. debt & grants · +€228M debt
Funding rounds
309
-6.1% vs H1 2022
Companies
302
Top country
UK
Rank among sectors
#4
9.9% of sector funding
Debt financing
€228M
7.7% of total
Top-10 round share
36.2%
of disclosed capital
Rounds ≥ €100M
7

Funding by month

€ raised vs rounds, by month
Healthtech — funding by month, H1 2023 — interactive chart.
Data table
FundingRounds
Jan€538M66
Feb€580M54
Mar€517M57
Apr€443M45
May€585M47
Jun€309M40

Top countries

by € raised
Healthtech — top countries by capital, H1 2023 — interactive chart.
Data table
Healthtech — top countries by capital, H1 2023
UK€589M
Germany€541M
France€527M
Switzerland€432M
Denmark€192M
Spain€108M
Sweden€107M
Netherlands€105M

Stage mix

by € raised
Healthtech — stage mix, H1 2023 — interactive chart.
Data table
Healthtech — stage mix, H1 2023
Other€1.0B
Series B€488M
Series C€467M
Series A€427M
Debt€228M
Seed€155M
Series D+€122M
Grant€48M
Pre-Seed€24M
Crowdfunding€3.1M
Early VC€2.5M
Growth/Late€1.0M

Exits & M&A

22 Acquisition · 1 Merger

23 exits · €246M disclosed.

VerogenAcquisitionJan 2023€140M
Odin VisionAcquisitionJun 2023€77M
Diamond WhitesAcquisitionFeb 2023€30M

Top deals

largest disclosed rounds in H1 2023
CompanyStageDateAmount
EvotecDebtFeb 2023€150M
DistalMotionOtherApr 2023€137M
Amolyt PharmaSeries CJan 2023€129M
Hemab TherapeuticsSeries BFeb 2023€127M
AscendOtherMay 2023€121M
Noema PharmaSeries BMar 2023€105M
Patient21Series CMay 2023€100M
HumbleOtherJun 2023€74M
Complement TherapeuticsSeries AApr 2023€72M
CorwaveSeries CJun 2023€61M
SoniVieSeries CJan 2023€56M
Moon SurgicalOtherMay 2023€51M
TissiumSeries D+May 2023€50M
NewBiologixSeries AMay 2023€46M
Grey Wolf TherapeuticsSeries BJan 2023€45M

Top investors

most active in H1 2023, by deal count